Edition:
United Kingdom

Prana Biotechnology Ltd (PRAN.OQ)

PRAN.OQ on NASDAQ Stock Exchange Capital Market

3.21USD
13 Dec 2017
Change (% chg)

$0.05 (+1.58%)
Prev Close
$3.16
Open
$3.15
Day's High
$3.28
Day's Low
$3.15
Volume
4,837
Avg. Vol
9,945
52-wk High
$4.57
52-wk Low
$1.59

Chart for

About

Prana Biotechnology Limited is a development-stage medical biotechnology company. The Company is engaged in the research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's disease, Huntington disease, Parkinson's disease and other neurological... (more)
No analyst recommendations are available for .

Overall

Beta: -0.10
Market Cap(Mil.): $29.76
Shares Outstanding(Mil.): 8.90
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 188.50 15.25
EPS (TTM): -- -- --
ROI: -- -11.67 33.27
ROE: -- -36.21 16.35

BRIEF-Prana Biotechnology files for mixed shelf of upto $50 mln

* Prana biotechnology ltd files for mixed shelf of upto $50 million - sec filing‍​ Source text for Eikon: (http://bit.ly/2hzNOVv) Further company coverage:

10 Oct 2017

BRIEF-Prana Biotechnology announces research collaboration with Takeda Pharmaceuticals International

* Announces research collaboration with Takeda Pharmaceuticals International

18 Jul 2017

BRIEF-Prana Biotechnology announces research collaboration with Takeda Pharmaceuticals

* announced a research collaboration with Takeda Pharmaceuticals International, Inc Source text for Eikon: Further company coverage:

18 Jul 2017

Earnings vs. Estimates